Measures of treatment effectiveness on tumour response and survival: A multi-state model approach

Statistics in Medicine

Volumn 19, Issue 6, 2000, Pages 837-848

  Chevret, Sylvie ^a,b   Leporrier, Michel ^c   Chastang, Claude ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE;

CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MEASUREMENT; MODEL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVIEW; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MARKOV CHAINS; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; VIDARABINE;

EID: 0034732317     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(20000330)19:6<837::AID-SIM394>3.0.CO;2-3     Document Type: Review

References (28)

1. Ellenberg S. Surrogate endpoints in clinical trials: cancer. Statistics in Medicine 1989; 8:405-413.
2. Kay R, Schumacher M. Unbiased assessment of treatment effects on disease recurrence and survival in clinical trials. Statistics in Medicine 1983; 2:41-58.
3. Lancar R, Kramar A, Haie-Meder C. Non-parametric methods for analysing recurrent complications of varying severity. Statistics in Medicine 1995; 14:2701-2712.
4. Pepe M. Inference for events with dependent risks in multiple endpoint studies. Journal of the American Statistical Association 1991; 86:770-778.
5. Pepe M, Longton G, Thornquist M. A qualifier q for the survival function to describe the prevalence of a transient condition. Statistics in Medicine 1991; 10:413-421.
6. Begg C, Larson M. A study of the use of the probability-of-being-in-response function as a summary of tumour response data. Biometrics 1982; 38:59-66.
7. Temkin N. An analysis for transient states with application to tumor shrinkage. Biometrics 1978; 34:571-580.
8. Glasziou P, Simes R, Gelber R. Quality adjusted survival analysis. Statistics in Medicine 1990; 9:1259-1276.
9. Buyse M, Piedboise P. On the relationship between response to treatment and survival time. Statistics in Medicine 1996; 15:2797-2812.
10. Piantadosi S, Byar D, Green S. The ecological fallacy. American Journal of Epidemiology 1988; 127:893-904.
11. Anderson J, Cain K, RG. Analysis of survival by tumor response. Journal of Clinical Oncology 1983; 1:710-719.
12. Bertino J. Guidelines for reporting clinical trials. Journal of Clinical Oncology 1986; 4:1.
13. Simon R, Wittes R. Methodologic guidelines for reports of clinical trials. Cancer Treatment Reports 1985; 69:1-3.
14. Cox D. Regression model and life tables (with discussion). Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
15. Mantel N, Byar D. Evaluation of response-time data involving transient states: An illustration using heart transplant data. Journal of the American Statistical Association 1974; 69:81-86.
16. Andersen P. Repeated assessment of risk factors in survival analysis. Statistical Methods in Biomedical Research 1992; 1:297-315.
17. Simon R, Makuch R. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Statistics in Medicine 1984; 3:35-44.
18. Leporrier M, Chevret S, Cazin B, Feugier P, Rapp M, Boudjerra N, Autran C, Dreyfus B, Desablens B, Dighiero G, Travade P, Chastang C. Randomized comparison of fludarabine, cap and chop, in 695 previously untreated stage b and c chronic lymphocytic leukemia (cll), early stopping of the cap accrual. Blood 1997; 90 (Suppl): 529a.
19. Andersen, P, Borgan O, Gill R, Keiding N. Statistical Models Based on Counting Processes. Springer-Verlag: New York, 1993.
20. Islam M. Multistate survival models for transitions and reverse transitions: an application to contraceptive use data. Journal of the Royal Statistical Society Series A 1994; 157:441-455.
21. Lin D. Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine 1994; 13:2233-2247.
22. Lee E, Wei L, Amato D. Cox type regression analysis for large numbers of small groups of correlated failure time observations. In Survival Analysis: the State of the Art, Klein JP, Goel PK (eds). Kluwer Academic Publishers: Dordrecht, 1992; 237-247.
23. Wei L, Lin D, Weissfield L. Regression analysis of multivariate incomplete failure time data. Journal of the American Statistical Association 1989; 84:1065-1073.
24. Kay R. A Markov model for analysing cancer markers and disease states in survival studies. Biometrics 1986; 42:855-865.
25. Klein J, Keiding N. Plotting summary predictions in multistate survival models: Probabilities of relapse and death in remission for bone marrow transplantation patients. Statistics in Medicine 1994; 13:2315-2332.
26. Li Q, Lagakos S. Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event. Statistics in Medicine 1997; 16:925-940.
27. Altman D, Goodman S. Transfer of technology from statistical journals to the biomedical literature. Journal of the American Medical Association 1994; 272:129-132.
28. O'Fallon J, Dubey S, Salsburg D, Edmonson J, Soffer A, Colton T. Should there be statistical guidelines for medical research papers? Biometrics 1978; 34:687-695.